BIT's 15th Annual Congress of International Drug Discovery Science and Technology - Japan 2017 (IDDST-Japan 2017)
★ Scientific Program

BIT's 15th Annual Congress of

International Drug Discovery Science and Technology - Japan 2017

Theme: Dedicated to Accelerating Drug Innovation

Time: July 25-27, 2017

Venue: Osaka, Japan

 

Keynote Forum Scientific Program
Section 1 Section 2 Section 3 Section 4 Section 5 Section 6 Young Scientist Forum

 

Section 3: Technologies in Drug Discovery
Session 301: Innovative Drug Discovery Technology
Day 1: Afternoon, Tuesday, July 25, 2017
13:00-17:30 
Place: Tatsuta, 5F, Guest Room Tower, HRO
Chair: Dr. Jan Hoflack, Chief Scientific and Operational Officer, Oncodesign SA, France
Time FaceOn Speeches and Speakers Org. Logo
13:00-13:05 Chair's Introduction
13:05-13:30 Title: The Use of Data Science to Discover Digital, Genetics and Imaging Clinical Biomarkers
Dr. Juergen Hammer,
Global Head of Data Science, Roche Innovation Center New York, USA
13:30-13:55 Title: Nanocyclix Probe-Based Drug Discovery: Next Generation Kinase Inhibitors Opening Up the Unexplored Kinome
Dr. Jan Hoflack,
Chief Scientific and Operational Officer, Oncodesign SA, France
13:55-14:20 Title: The Industrialization of Discovery: Leveraging Automation and Artificial Intelligence to Achieve Discovery at Scale
Dr. Chris Gibson,
Co-Founder and CEO, Recursion Pharmaceuticals, USA
14:20-14:45 Title: Design of Novel Selective Melanocortin 1 Receptor Ligands to Target Melanoma
Dr. Minying Cai,
Research Professor, University of Arizona, USA
14:45-15:10 Title: Use of a New Generation of Nanobubbles for Ultrasound Theranostics
Dr. Katsuro Tachibana,
Professor, Fukuoka University School of Medicine, Japan
15:10-15:25 Coffee Break
15:25-15:50 Title: Ligand-directed Targeting and Molecular Imaging Based on Vascular Zip Codes Revealed by in Vivo Phage Display
Dr. Renata Pasqualini,
Professor, University of New Mexico, USA
15:50-16:15 Title: Quantitative Measurement of Cellular Events with Image Processing and
Data Mining for Drug Discovery and Therapy, and System Biology

Dr. Petra Perner,
Director, Institute of Computer Vision and Applied Computer Sciences, IBaI, Germany
16:15-16:40 Title: Label-free Morphology-based Cellular Evaluation Based on Phase-contrast Microscopic Images
Dr. Ryuji Kato,
Associate Professor, Graduate School of Pharmaceutical Sciences, Nagoya University, Japan
16:40-17:05 Title: Innovations in Pharmaceutical Sciences – Help of Nature, Regenerative Medicines and Nanotechnology
Dr. Pradyumn G. Shrotriya,
Director, Pharma Research, School of Pharmacy and Technology Management, SVKM’s NMIMS University, India
17:05-17:30 Title: Predicting before Synthesizing: Successful and Future Cases of Computational Chemistry in Drug Design
Dr. Jose Pedro Ceron-Carrasco,
Assistant Professor, Saint Anthony Catholic University of Murcia, Spain

 

Session 302: Emerging Drug Screening Technology
Day 2: Morning, Wednesday, July 26, 2017
08:30-12:35 
Place: Tatsuta, 5F, Guest Room Tower, HRO
Chair: Dr. Alexei G. Basnakian, Professor, University of Arkansas for Medical Sciences, USA
Time FaceOn Speeches and Speakers Org. Logo
08:30-08:35 Chair's Introduction
08:35-09:00 Title: Screening with Multi Parametric Phenotypic High Content Imaging
Dr. Dana Nojima,
Senior Scientist, Amgen Inc., USA
09:00-09:25 Title: Pre/postmortem Nuclear DNA Fragmentation: A Mechanistic Marker of Irreversible Toxic Tissue Injury and a Target for High Throughput Drug Discovery
Dr. Alexei G. Basnakian,
Professor, University of Arkansas for Medical Sciences, USA
09:25-09:50 Title: Cell-in-Gel System for High-throughput Cardiotoxicity Screening and High-content Drug Discovery
Dr. Ye Chen-Izu,
Associate Professor, University of California, Davis, USA
09:50-10:15 Title: Discovering Novel Tuberculosis Drugs through High Throughput Screening
Dr. Umayal Lakshmanan,
Project Leader, Experimental Therapeutics Centre, A*STAR, Singapore
10:15-10:30 Coffee Break
10:30-10:55 Title: Effective Cell-Free Drug Screening Protocol for Protein-Protein Interaction
Dr. Rivka Dikstein,
Professor, Department of Biomolecular Sciences, The Weizmann Institute of Science, Israel
10:55-11:20 Title: Models of the Ion Channels with Unknown Structure Based on EM Data, and Homology Modelling for Drug Discovery
Dr. Olga S. Sokolova,
Associate Professor, Moscow Lomonosov University, Russia
11:20-11:45 Title: Identification of Inhibitors for the Lutheran–laminin Interaction by Molecular Modelling Techniques to Reduce the Vaso-occlusive Crises of Sickle Cell Disease
Dr. Fabrice Gardebien,
Assistant Professor, Laboratory DSIMB, University of Reunion, France
11:45-12:10 Title: Tethered Ribozyme Ligation – A Solution-based Proximity Detection System to Identify Active Substances
Dr. Stanislav Engel,
Assistant Professor, Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University, Israel
 
12:10-12:35 Title: Pitfalls of Virtual Screening: Presentation and Solutions
Dr. Liliane Mouawad,
Researcher, Institut Curie, France

 

Session 303: Detection and Analysis Technology in Drug Discovery
Day 2: Afternoon, Wednesday, July 26, 2017
13:00-17:30 
Place: Tatsuta, 5F, Guest Room Tower, HRO
Chair: Dr. Frank Schleifenbaum, Head, Berthold Technologies GmbH & Co. KG, Germany
Time FaceOn Speeches and Speakers Org. Logo
13:00-13:05 Chair's Introduction
13:05-13:30 Title: Modern Chemistry: Tools to Enable the Practicing Chemist
Dr. Sarah Trice,
Head of Innovation, Chemical Synthesis, Merck (MilliPoreSigma), USA
13:30-13:55 Title: SCORE: A New Label-Free Technology for Microarray-Based Molecular Interaction Studies
Dr. Frank Schleifenbaum,
Head, Berthold Technologies GmbH & Co. KG, Germany
13:55-14:20 http://www.dnaday.com/images/psp/no.jpg Title: The xCELLigence Impedance Monitoring Instrument Enabling Label-free Real-time Assay in Drug Discovery and Development 
Dr. Eiji Okubo,
Country Manager, APAC North and Japan, ACEA Biosciences, Inc., USA
14:20-14:45 Title: The Paradigm Shift of DNA Sequencing: Its Role in CDx and Beyond
Dr. William Cheung,
Senior Scientist, DiagCor Biosciences Inc. Ltd., Hong Kong, China
14:45-15:10 Title: A Flow Cytometry-based Reporter Assay for the Identification of Nonsense Mutation Read-through Therapeutics
Dr. Rina Rosin-Arbesfeld,
Professor, Tel Aviv University, Israel
15:10-15:25 Coffee Break
15:25-15:50 Title: Detection of Protein-ligand Interactions for Drug Discovery and Intelligent Drug Design
Dr. Yu-Hwa Lo,
Professor, University of California, San Diego, USA
15:50-16:15 Title: MAPPIT and Co: Analytical and High-throughput Protein-Protein and Protein-Small Molecule Interaction Mapping in Human Cells
Dr. Jan Tavernier,
Chair, Department of Biochemistry, Center for Medical Biotechnology, VIB, Ghent University, Belgium
16:15-16:40 Title: Mass Spectrometry-Based Technologies and Clinical Proteogenomics for Developments of Effective Drugs / Therapeutic Targets
Dr. Toshihide Nishimura,
Professor, Translational Medicine Informatics, St. Marianna University School of Medicine, Japan
16:40-17:05 Title: Turbidimetry: A New Look for Microbiological Analyses
Dr. Ana Carolina Kogawa,
Post-doc, Universidade Estadual Paulista – UNESP, Brazil
17:05-17:30 Title: Screening of Suppressing Activity Using Rice Leaf Explant for Antibacterial from Compound or Extract Libraries
Dr. Jeong-Gu Kim,
Agricultural Researcher, National Academy of Agricultural Science, South Korea

  

Hosting Organization
whtslogo.JPG
World High Technology Society
Operating Organization
BIT Group Global Ltd.
Supporting Organizations

Keio University School of Medicine, Japan

Nagoya University Graduate School of Pharmaceutical Sciences, Japan

Shenzhen International Institute for Biomedical Research, China

Official Travel Agency
Media Partners

Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2016-2017 BIT Group Global Ltd.